Skip to evidence report

NEU.INH_VIP.develop_niche: Studies — page 9

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 122 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 8,001–9,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for NEU.INH_VIP.develop_niche
#Trait / studyIndividual trait IDMean IC score
8001CGA levelsGCST904687323.97e-03
8002HDL cholesterolGCST0007553.97e-03
8003CKAP4/LAMP3 ratioGCST903140733.97e-03
8004Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)FING000007493.97e-03
8005Abnormalities of forces of labourFING000000033.97e-03
8006PLXNB2 levelsGCST904702663.96e-03
8007GZMA/TNFRSF8 ratioGCST903150143.95e-03
8008aseg rh intensity Cerebellum-CortexGCST900037813.95e-03
8009LDL cholesterolGCST0007593.95e-03
8010Saturated fatty acids to total fatty acids percentageGCST904999583.95e-03
8011SOD3 levelsGCST904707063.95e-03
8012CD46/SIAE ratioGCST903138353.95e-03
8013Creatinine levelsGCST902786243.94e-03
8014Haemorrhoidal diseaseGCST900140333.94e-03
8015ISEI occupational scoreGCST904461603.94e-03
8016T1 FreeSurfer DK lh precentral thicknessGCST903856453.93e-03
8017SLITRK6 levelsGCST904706713.93e-03
8018IDP dMRI TBSS MO Superior corona radiata RGCST900039763.92e-03
8019Prolapse of vaginal walls | genitourinaryUKBB000007123.92e-03
8020Forced expiratory volume in 1-second (FEV1) | SpirometryUKBB000002513.92e-03
8021ICD10 O12: Gestational oedema and proteinuria without hypertensionGCST904542313.92e-03
8022Cystatin C levels in bottom 99% of individuals by creatinine levelsGCST905667343.92e-03
8023CD79B/TNFRSF13B ratioGCST903139023.92e-03
8024Eosinophil countGCST0046063.92e-03
8025Pregnenolone sulfate levelsGCST901998733.91e-03
8026CDH17 levelsGCST904686693.91e-03
8027Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T136ECGU0001363.91e-03
8028Blood urea nitrogen (BUN, maximum, inv-norm transformed)GCST904751623.91e-03
8029RNF43 levelsGCST904704863.90e-03
8030Primary open-angle glaucoma, strictFING000012143.90e-03
8031Triglycerides in very large HDL (UKB data field 23557)GCST902696543.90e-03
8032pro-brain natriuretic peptide (proBNP, mean, inv-norm transformed)GCST904763123.90e-03
8033aparc-a2009s lh volume S-calcarineGCST900029683.89e-03
8034ANKRD54 levelsGCST904683113.88e-03
8035Total lipids in small VLDLGCST904998493.88e-03
8036Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurementUKBB000008113.86e-03
8037aparc-DKTatlas rh area insulaGCST900032963.86e-03
8038IDP dMRI TBSS MO Posterior corona radiata RGCST900039783.86e-03
8039OLFM4 levelsGCST904701213.85e-03
8040PLA2G15/SMPDL3A ratioGCST903156633.85e-03
8041Takes medication for high cholesterol?GCST904752083.85e-03
8042Sebaceous cyst (PheCode 706.2)GCST904762133.85e-03
8043X-24544 levelsGCST902006363.84e-03
8044SPTLC1 levelsGCST904271303.84e-03
8045Concentration of VLDL particlesGCST905002503.84e-03
8046Diseases of the digestive systemFING000004293.83e-03
8047UGDH levelsGCST904710063.83e-03
8048Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T258ECGA0002583.83e-03
8049AGRP levelsGCST904682563.82e-03
8050DNMBP levelsGCST904690233.82e-03
8051Operation code - hip replacement/revision | OperationsUKBB000005583.82e-03
8052Urine X-24796 levels in chronic kidney diseaseGCST902668003.81e-03
8053S100A13 levelsGCST904705143.81e-03
8054Citrate levelsGCST904972063.81e-03
8055Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T6ECGA0000063.81e-03
8056OGN levelsGCST904701193.81e-03
8057Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T103ECGU0001033.80e-03
8058Allergic contact dermatitisFING000000683.80e-03
8059TOR1AIP1 levelsGCST904709353.80e-03
8060TDP1 levelsGCST904708263.80e-03
8061Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T275ECGA0002753.80e-03
8062LRP11/ROR1 ratioGCST903153303.79e-03
8063Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemiaGCST906247443.79e-03
8064Ximenoylcarnitine (C26:1) levelsGCST902001493.79e-03
8065Pulse pressure, combined automated + manual reading | Cardiovascular measurementUKBB000007193.79e-03
8066CC2D1A/CRADD ratioGCST903136633.78e-03
8067Lysophosphatidylcholine (26:0) [sn2] levelsGCST900254283.78e-03
8068EIF4G1 levelsGCST904690973.78e-03
8069Appendicular lean massGCST900000273.78e-03
8070Urine glucosaminate levels in chronic kidney diseaseGCST902651793.78e-03
8071DARS1/USP8 ratioGCST903144073.77e-03
8072T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125)GCST903209443.77e-03
8073Celiac disease (PheCode 557.1)GCST900441583.77e-03
8074Left ventricular end systole anterospetal wall thicknessGCST902785133.76e-03
8075DTI TBSS MO Middle cerebellar peduncleGCST903846203.76e-03
8076CD46/TIMP1 ratioGCST903138373.76e-03
8077CR2 levelsGCST904688523.75e-03
8078Histidine levels (UKB data field 23463)GCST902695603.75e-03
8079Principal component-derived dietary pattern 58GCST901330613.75e-03
8080Other noninflammatory disorders of uterus, except cervixFING000010793.74e-03
8081Phospholipids to total lipids in very large VLDL percentage (UKB data field 23584)GCST902696813.74e-03
8082Right-hemisphere visual network to right-hemisphere control network white-matter structural connectivityGCST903027793.74e-03
8083Basophil count varianceGCST905656823.74e-03
8084Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000007163.74e-03
8085IDP dMRI TBSS L3 Cingulum hippocampus RGCST900042073.72e-03
8086Free cholesterol in small HDL (UKB data field 23577)GCST902696743.71e-03
8087Ascending aorta strainGCST902673883.70e-03
8088RBP5 levelsGCST904704393.69e-03
8089Middle diffusion tensor imaging along the perivascular space indexGCST904555443.69e-03
8090TNC/VCAM1 ratioGCST903159273.69e-03
8091Duodenal ulcerGCST902709283.69e-03
8092CPM levelsGCST902405983.68e-03
80935-hydroxyindole sulfate levelsGCST902000503.68e-03
8094GSR levelsGCST904694103.67e-03
8095Urine X-24798 levels in chronic kidney diseaseGCST902668023.67e-03
8096Creatinine levelsGCST901327193.67e-03
8097Corneal resistance factorGCST901005683.67e-03
8098GPRC5C levelsGCST904693983.66e-03
8099Hypothyroidism, drug reimbursementFING000006553.66e-03
8100Enterocolitis due to Clostridium difficileFING000005073.66e-03
8101HEXIM1 levelsGCST904694473.65e-03
8102Triglycerides in medium LDL (UKB data field 23543)GCST902696403.64e-03
8103Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T140ECGU0001403.64e-03
8104CTSZ/SMPDL3A ratioGCST903143223.63e-03
8105GNPDA2 levelsGCST904693743.63e-03
8106Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T255ECGU0002553.62e-03
8107Octadecenedioylcarnitine (C18:1-DC) levelsGCST901999703.62e-03
8108IL2RB levelsGCST904695863.62e-03
8109aparc-a2009s rh volume S-collat-transv-antGCST900030483.62e-03
8110Operation code - spinal laminectomy | OperationsUKBB000005643.61e-03
8111MESD/WWP2 ratioGCST903154263.60e-03
8112EDAR/SDC4 ratioGCST903145853.60e-03
8113CXCL3/MGLL ratioGCST903143453.60e-03
8114Appendicular lean massGCST900000253.59e-03
8115ENPP2 levelsGCST904691153.59e-03
8116Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T89ECGU0000893.59e-03
8117Male-pattern baldnessGCST0066613.59e-03
8118ITGB5/S100A4 ratioGCST903152333.59e-03
8119Ratio of omega-6 fatty acids to total fatty acidsGCST900929353.59e-03
8120HAVCR1 levelsGCST904694313.59e-03
8121T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64)GCST903208833.58e-03
8122Low density lipoprotein cholesterol levelsGCST902786383.58e-03
8123Phospholipids to Total Lipids in Small VLDL percentageGCST904998953.58e-03
8124BTN2A1/SMOC2 ratioGCST903135493.57e-03
8125IMPACT levelsGCST904696113.57e-03
8126FAM3B levelsGCST904691863.57e-03
8127IPCEF1/SMAD1 ratioGCST903151853.57e-03
8128TNFSF11 levelsGCST900120443.56e-03
8129DAG1/F2R ratioGCST903143743.56e-03
8130Offspring birth weightGCST0053143.56e-03
8131IDP dMRI TBSS L2 External capsule LGCST900041563.55e-03
8132TBC1D5 levelsGCST904708113.55e-03
8133ACY3 levelsGCST904682133.54e-03
8134GPR15L levelsGCST904693963.54e-03
8135Autoimmune diseasesFING000001313.54e-03
8136Percentage of trisyalated structures in total plasma glycans (GP97)GCST906685413.54e-03
8137FABP5 levelsGCST904691773.54e-03
8138FCRL1/TCL1A ratioGCST903147953.53e-03
8139Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T32ECGA0000323.53e-03
8140Citrate levelsGCST904972003.52e-03
8141CDKN2D/MANF ratioGCST903139893.52e-03
8142aseg lh intensity PallidumGCST900037713.51e-03
8143Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)FING000001433.51e-03
8144MMP1/MMP3 ratioGCST903154613.50e-03
8145SERPINI1 levelsGCST904706023.50e-03
8146CD34 levelsGCST904686263.50e-03
8147APOA1 levelsGCST902695373.50e-03
8148STIP1 levelsGCST904707643.49e-03
8149IL15/IL18BP ratioGCST903151483.49e-03
8150rfMRI amplitudes (ICA100 node 11)GCST900045993.49e-03
8151Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)GCST901322273.49e-03
8152JAM2/TGFBR2 ratioGCST903152383.48e-03
8153Pustulosis palmaris et plantarisFING000012333.48e-03
8154Type 1 diabetes, definitions combinedFING000013803.47e-03
8155Triglycerides in IDL (UKB data field 23529)GCST902696263.47e-03
8156Triacylglycerol_47:4_[M+NH4]1+ levelsGCST900603913.46e-03
8157Acute pulmonary heart disease (PheCode 415.1)GCST904759443.46e-03
8158Liver iron contentGCST900166743.46e-03
8159CDHR5 levelsGCST904686803.46e-03
8160Lymphoid neoplasms (B-cell phenocluster)GCST906247363.45e-03
8161ALCAM/CDH5 ratioGCST903132343.45e-03
8162Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T128ECGA0001283.45e-03
8163IFIH1 levelsGCST904236893.44e-03
8164Polyunsaturated fatty acid levelsGCST905021403.43e-03
8165Phospholipids to Total Lipids in Large HDL percentageGCST904978683.43e-03
8166Mean reticulocyte volumeGCST900259753.43e-03
8167APPL2 levelsGCST904683433.43e-03
8168SERPINE2 levelsGCST904705973.43e-03
8169Behenoyl dihydrosphingomyelin (d18:0/22:0) levelsGCST902000593.43e-03
8170TCTN3 levelsGCST904708233.42e-03
8171Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T93ECGU0000933.42e-03
8172FUT8/TNFSF14 ratioGCST903148953.42e-03
8173Volume of right accessory basal nucleusGCST904749073.42e-03
8174Benign neoplasm: ChoroidFING000001703.42e-03
8175Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T34ECGA0000343.42e-03
8176CXCL8 levelsGCST904689343.41e-03
8177TIMP3 levelsGCST904708713.40e-03
8178Operation code - coronary artery bypass grafts (cabg) | OperationsUKBB000005563.40e-03
8179CLTA levelsGCST904687913.40e-03
8180CD1C/CD207 ratioGCST903137453.39e-03
8181CPXM1/LGMN ratioGCST903142203.39e-03
8182GSTA1/SULT2A1 ratioGCST903149963.38e-03
8183FOLH1 levelsGCST904256613.38e-03
8184NOMO1 levelsGCST904700603.38e-03
8185Phospholipids in large LDLGCST904980533.37e-03
8186CALCOCO1 levelsGCST904685303.36e-03
8187F2R/SNX9 ratioGCST903147363.36e-03
8188Glaucoma (primary open-angle)GCST900117683.36e-03
8189BANK1 levelsGCST904684213.36e-03
8190Basophil countGCST900022933.36e-03
8191Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T52ECGA0000523.35e-03
8192Plasma ascorbic acid 2-sulfate levels in chronic kidney diseaseGCST902648323.35e-03
8193Polyunsaturated fatty acid levelsGCST905021423.34e-03
8194Plasma N,N,N-trimethyl-5-aminovalerate levels in chronic kidney diseaseGCST902656713.34e-03
8195Childhood asthma (age<16) (more control exclusions)FING000002703.33e-03
8196MMP9/PLAUR ratioGCST903154703.33e-03
8197ART3/GPC1 ratioGCST903133613.33e-03
8198Mean corpuscular volumeGCST900023923.33e-03
8199Hearing difficulty and hearing difficulty with background noiseGCST902457683.33e-03
8200ENO2/TACC3 ratioGCST903146703.33e-03
8201Treatment/medication code - metformin | MedicationsUKBB000008513.33e-03
8202Phospholipids in medium HDL (UKB data field 23567)GCST902696643.32e-03
8203SMAD1/ZBTB16 ratioGCST903158533.31e-03
8204Succinoyltaurine levelsGCST902002353.31e-03
8205Dysmenorrheic pain severityGCST0066563.31e-03
8206MPHOSPH8 levelsGCST904699343.31e-03
8207CALCOCO1/TJAP1 ratioGCST903136113.30e-03
8208IDP SWI T2star right pallidumGCST900038703.30e-03
8209HematocritGCST0046043.29e-03
8210IDP dMRI ProbtrackX L1 cgc rGCST900042513.29e-03
8211T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79)GCST903206423.28e-03
8212Diastolic blood pressure, manual reading | Blood pressureUKBB000001803.28e-03
8213ILKAP levelsGCST904696083.28e-03
8214Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T43ECGA0000433.27e-03
8215CST3/IGFBP6 ratioGCST903142933.27e-03
8216ESAM/FUT8 ratioGCST903147113.27e-03
8217Creatinine levelsGCST904972363.26e-03
8218Concentration of small VLDL particlesGCST904998683.26e-03
8219Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levelsGCST900602953.25e-03
8220HNRNPK levelsGCST904694693.25e-03
8221IDP T1 FAST ROIs R intracalc cortexGCST900024983.25e-03
8222FKBP7 levelsGCST904692453.24e-03
8223Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T85ECGA0000853.24e-03
8224PBLD levelsGCST904701633.23e-03
8225CEACAM21 levelsGCST904686943.22e-03
8226SPINT2 levelsGCST904707283.21e-03
8227APRT/PSME1 ratioGCST903133383.21e-03
8228Fasting plasma glucoseGCST905664203.21e-03
8229BCAN/NPTXR ratioGCST903134823.20e-03
8230TXLNA levelsGCST904709893.20e-03
8231Gamma-CEHC levelsGCST901998643.20e-03
8232Free Cholesterol in VLDLGCST905002173.20e-03
8233EPPK1 levelsGCST904691373.20e-03
8234GRAP2/SNX9 ratioGCST903149883.20e-03
8235PTPN1/WWP2 ratioGCST903157463.19e-03
8236AHCY/HSPA1A ratioGCST903132113.19e-03
8237Cholesterol to Total Lipids in Medium HDL percentageGCST904985193.19e-03
8238OTUD6B levelsGCST904701363.19e-03
8239AmygNuclei rh volume Central-nucleusGCST900026623.19e-03
8240Low-density lipoprotein levels (MTAG)GCST901791483.17e-03
8241CCL13/CCL17 ratioGCST903136743.17e-03
8242Triacylglycerol_54:4_[M+NH4]1+ levelsGCST900605403.17e-03
8243DAPK2 levelsGCST902408773.17e-03
8244SEMA4D/TXNDC5 ratioGCST903158243.16e-03
8245Operation code - spine or back surgery | OperationsUKBB000005653.16e-03
8246CD83/IL12A_IL12B ratioGCST903139053.16e-03
8247Phosphoglycerides levelsGCST904992653.15e-03
8248CORO1A levelsGCST904688323.15e-03
8249OMD/SPP1 ratioGCST903155863.15e-03
8250Eosinophill percentage (UKB data field 30210)GCST904680693.15e-03
8251Female genital prolapse | Noninflammatory disorders of female genital tractUKBB000002443.14e-03
8252CETN2/PRTFDC1 ratioGCST903140303.14e-03
8253PARP1 levelsGCST904701603.14e-03
8254EIF4B levelsGCST904690943.13e-03
8255Operative procedures - Angiocardiography of left side of heart NEC | Summary OperationsUKBB000005723.13e-03
8256MTSS2 levelsGCST904699613.13e-03
8257PODXL2/SCG3 ratioGCST903157003.13e-03
8258ANXA3/ENO2 ratioGCST903132813.12e-03
8259CSF1 levelsGCST904688813.12e-03
8260Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T227ECGU0002273.11e-03
8261AXIN1 levelsGCST904684053.10e-03
8262CD46/SELP ratioGCST903138343.10e-03
8263HMOX2 levelsGCST904694663.10e-03
8264T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 85)GCST903209043.10e-03
8265Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T485ECGU0004853.10e-03
8266IDP dMRI TBSS ISOVF Superior corona radiata RGCST900045013.10e-03
8267Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T81ECGA0000813.10e-03
8268HNMT/SETMAR ratioGCST903150693.09e-03
8269Total phospholipid levels in lipoprotein particlesGCST905001103.09e-03
8270Lung function (FVC)GCST0074293.09e-03
8271Hip fractureGCST901612403.09e-03
8272hemoglobin (maximum, inv-norm transformed)GCST904753723.09e-03
8273DNAJB14 levelsGCST904272353.08e-03
8274Type 2 diabetesGCST904681513.08e-03
8275DIABLO/DOK2 ratioGCST903144643.08e-03
8276CD160 levelsGCST904685993.08e-03
8277Oral glucose tolerance test-0hGCST905664213.07e-03
8278LGALS8/TXNDC5 ratioGCST903153213.06e-03
82793-hydroxybutyrate levels (UKB data field 23474)GCST902695713.06e-03
8280High-grade serous epithelial ovarian cancerGCST902441683.06e-03
8281Birth year infant mortality ratesGCST900950473.06e-03
8282LBR/LGALS8 ratioGCST903152943.06e-03
8283MATN2 levelsGCST904698643.06e-03
8284FCGR2B/NOS3 ratioGCST903147943.06e-03
8285SCARA5/TGFBI ratioGCST903158093.06e-03
8286CD69/PPP1R2 ratioGCST903138823.05e-03
8287Total testosterone levelsGCST900121143.05e-03
8288RRM2 levelsGCST904705013.05e-03
8289CA4/TGFBR2 ratioGCST903135883.03e-03
8290Chronic obstructive pulmonary disease x current smoker interaction (main effect)GCST900165913.03e-03
8291ESAM/JAM2 ratioGCST903147123.03e-03
8292Melanocytic naevi of trunkFING000008003.03e-03
8293Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T261ECGA0002613.02e-03
8294diastolic blood pressure (DBP, mean, inv-normal transformed)GCST904752553.02e-03
8295Graves' diseaseGCST900186273.02e-03
8296TNFAIP8 levelsGCST904708983.02e-03
8297Neurofibromatosis, type 2FING000008673.01e-03
8298Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T467ECGU0004673.01e-03
8299CD58 levelsGCST904686383.01e-03
8300CEACAM16 levelsGCST904686893.01e-03
8301Diffuse idiopathic skeletal hyperostosis flow scoreGCST901345323.00e-03
8302Type 1 diabetesGCST900137912.99e-03
8303DPP6/NRCAM ratioGCST903145422.98e-03
8304Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T47ECGA0000472.98e-03
8305Hemoglobin concentrationGCST900023102.97e-03
8306Haematocrit percentage | Blood countUKBB000002922.97e-03
8307CD83/TNFRSF4 ratioGCST903139072.97e-03
8308AGRP levelsGCST902402172.96e-03
8309PON2/PON3 ratioGCST903157032.96e-03
8310Monounsaturated fatty acids to total fatty acids percentageGCST905023892.96e-03
8311Non-mucinous epithelial ovarian cancerGCST902441672.96e-03
8312Thyroid stimulating hormone levels within normal range in pregnancyGCST904351952.95e-03
8313PKLR/UBAC1 ratioGCST903156602.95e-03
8314DNAJA2/HCLS1 ratioGCST903145022.95e-03
8315Blood urea nitrogen (BUN, mean, inv-norm transformed)GCST904751652.95e-03
8316Breast cancerGCST0072362.94e-03
8317T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79)GCST903208982.94e-03
8318Small cell lung carcinomaGCST0047462.94e-03
8319Cerebrospinal fluid 3-hydroxy-2-ethylpropionate levelsGCST903179642.94e-03
8320CDSN/WFDC12 ratioGCST903139992.94e-03
8321Hip minimal joint space widthGCST902813652.93e-03
8322NUDC levelsGCST904701022.93e-03
8323EGFL7 levelsGCST904690832.93e-03
8324Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T122ECGA0001222.93e-03
8325Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T37ECGA0000372.93e-03
8326Phosphoglycerides levelsGCST904992592.92e-03
8327wg rh intensity-contrast parahippocampalGCST900038422.91e-03
8328Systemic connective tissue disordersFING000013502.91e-03
8329C20:4 Lysophosphatidylcholine levels in chronic kidney diseaseGCST902575702.91e-03
8330RBFOX3 levelsGCST904704322.91e-03
8331Chronic pain (confirmatory factor analysis Factor 18)GCST903093522.91e-03
8332aparc-Desikan lh volume cuneusGCST900027722.91e-03
8333Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T33ECGA0000332.90e-03
8334Right-hemisphere visual network to right-hemisphere visual network white-matter structural connectivityGCST903027742.90e-03
8335Polyunsaturated fatty acid levelsGCST904992662.90e-03
8336MEPE/SOST ratioGCST903154202.89e-03
8337Fracture of forearmGCST902812732.88e-03
8338T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57)GCST903208762.88e-03
8339mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST904754502.88e-03
8340IDP dMRI TBSS ICVF Cingulum hippocampus LGCST900043642.88e-03
8341ATG4A/NSFL1C ratioGCST903133682.88e-03
8342Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T218ECGU0002182.88e-03
8343UBXN1 levelsGCST904710042.88e-03
8344Inguinal hernia | digestiveUKBB000003622.87e-03
8345high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)GCST904753502.87e-03
8346Mild obesity-related type 2 diabetesGCST900264152.87e-03
8347CPA1/PLA2G1B ratioGCST903142052.87e-03
8348MPI/TACC3 ratioGCST903154912.87e-03
8349Haemoglobin concentration | Blood countUKBB000002932.87e-03
8350Facial pigmentation measurement (UV light)GCST900022832.86e-03
8351RCC1 levelsGCST904704432.86e-03
8352Nerve, nerve root and plexus disordersFING000008622.86e-03
8353FUT8/SORT1 ratioGCST903148922.85e-03
8354Other disorders of veinsFING000010402.85e-03
8355TG levelsGCST904708512.85e-03
8356CYB5R2 levelsGCST904689372.85e-03
8357PolyarthrosisFING000011812.84e-03
8358aseg rh volume Cerebellum-CortexGCST900026362.84e-03
8359Phospholipids to total lipids ratio in small HDLGCST900929532.84e-03
8360wg rh intensity-contrast superiortemporalGCST900038562.83e-03
8361Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T9ECGA0000092.83e-03
8362Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T97ECGU0000972.83e-03
8363Triglycerides in HDL (UKB data field 23410)GCST902695072.83e-03
8364Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T121ECGA0001212.83e-03
8365Biological Sibling: AsthmaGCST904763722.82e-03
8366Inguinal hernia | HerniaUKBB000003632.81e-03
8367CASP3/SERPINB9 ratioGCST903136422.81e-03
8368PTPRF levelsGCST904703812.81e-03
8369IL15 levelsGCST904695562.80e-03
8370Glutamine levels (UKB data field 23461)GCST902695582.80e-03
8371FOXO3 levelsGCST904692662.80e-03
8372Irregular menstrual cycle/bleeding | genitourinaryUKBB000003792.80e-03
8373Ulcerative colitisGCST0041332.80e-03
8374LDL cholesterolGCST0022222.79e-03
8375IDP dMRI ProbtrackX ICVF cgh lGCST900043812.79e-03
8376Blood urea nitrogen (BUN, minimum, inv-norm transformed)GCST904751682.79e-03
8377SPART levelsGCST904707192.78e-03
8378Renal failure (PheCode 585)GCST904761182.78e-03
8379ZNRD2 levelsGCST904711032.78e-03
8380AMBP/HYOU1 ratioGCST903132552.77e-03
8381AcneFING000000102.76e-03
8382Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T145ECGU0001452.76e-03
8383Phospholipid levels in medium HDLGCST900929002.76e-03
8384Glaucoma, exfoliationFING000005802.76e-03
8385Sicca syndrome [Sjögren]FING000013042.76e-03
8386Platelet count at deliveryGCST903022272.76e-03
8387aseg global volume 4th-VentricleGCST900026002.76e-03
8388CALCOCO1/INPPL1 ratioGCST903136032.76e-03
8389aseg global volume-ratio BrainSegVol-to-eTIVGCST900026122.75e-03
8390Dermatophytosis of nail (PheCode 110.11)GCST904755622.75e-03
8391GLOD4 levelsGCST904693592.74e-03
8392Glaucoma (primary open-angle)GCST900117662.74e-03
8393Total fatty acid levelsGCST905027232.74e-03
8394Rheumatoid arthritisFING000012672.74e-03
8395Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 8.07_212.10)GCST902918052.73e-03
8396Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000007212.73e-03
8397Pulse pressure, automated reading | Cardiovascular measurementUKBB000007152.73e-03
8398PRSS8 levelsGCST904703452.73e-03
8399PAFAH1B3 levelsGCST904701452.73e-03
8400Chronic obstructive pulmonary disease in non-current smokersGCST900165942.73e-03
8401Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T1ECGA0000012.73e-03
8402CA13/TYMP ratioGCST903135682.73e-03
8403Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T124ECGA0001242.72e-03
8404IDP SWI T2star right putamenGCST900038682.72e-03
8405DCTN6 levelsGCST904689602.72e-03
8406Pulse pressureGCST904727852.71e-03
8407Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditionsUKBB000005182.71e-03
8408X-13435 levelsGCST902438112.71e-03
8409aparc-a2009s lh area G-cuneusGCST900033072.71e-03
8410AXIN1/NFATC1 ratioGCST903134152.71e-03
8411Qualifications - NVQ or HND or HNC or equivalent | EducationUKBB000007302.71e-03
8412Lysophosphatidylethanolamine-P_20:0_[M-H]1- levelsGCST900601472.71e-03
8413CLPS/PLA2G1B ratioGCST903141402.70e-03
8414IDP dMRI TBSS MD Cerebral peduncle LGCST900040422.70e-03
8415HEXIM1/NUB1 ratioGCST903150492.70e-03
8416PIKFYVE levelsGCST904702352.70e-03
8417Calcium levels (UKB data field 30680)GCST904680652.69e-03
8418IQGAP2/STX4 ratioGCST903151902.69e-03
8419TPK1 levelsGCST904709432.69e-03
8420Carcinoma in situ of breast, intraductal (controls excluding all cancers)FING000002402.69e-03
8421Calcium levelsGCST900259902.69e-03
8422PTPRM/SELE ratioGCST903157532.69e-03
8423MMP1/SERPINB6 ratioGCST903154622.69e-03
8424Myocardial infarction | circulatory systemUKBB000004912.69e-03
8425MOCS2 levelsGCST904699282.69e-03
8426Basal cell carcinoma, excluding all cancers (controls excluding all cancers)FING000001422.68e-03
8427DOK2/SNX9 ratioGCST903145392.68e-03
8428CPB1/REG1B ratioGCST903142132.68e-03
8429BIN2/TMSB10 ratioGCST903135152.68e-03
8430MITD1/WWP2 ratioGCST903154582.67e-03
8431Saturated fatty acids levelsGCST905026592.67e-03
8432Plasma cystathionine levels in chronic kidney diseaseGCST902649742.67e-03
8433BSG levelsGCST904684722.66e-03
8434CDC27 levelsGCST904686642.66e-03
8435SNCG levelsGCST904706952.66e-03
8436DPP7 levelsGCST904690352.66e-03
84375alpha-androstan-3beta,17beta-diol disulfate levelsGCST901998352.66e-03
8438Triacylglycerol_50:3_[M+NH4]1+ levelsGCST900604682.66e-03
8439Volume of right cortico-amygdaloid transition areaGCST904750182.65e-03
8440PCBP2 levelsGCST904701672.65e-03
8441MAP2 levelsGCST904698532.65e-03
8442ADM/CLMP ratioGCST903131972.64e-03
8443Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T184ECGU0001842.64e-03
8444Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T66ECGA0000662.64e-03
8445eosinophil (fraction, maximum, inv-norm transformed)GCST904752972.64e-03
8446Valine levelsGCST905001772.63e-03
8447TBCC/WWP2 ratioGCST903159112.63e-03
8448F7/VASN ratioGCST903147452.63e-03
8449RRM2B/SMAD1 ratioGCST903157882.63e-03
8450IDP dMRI TBSS ICVF Cerebral peduncle RGCST900043412.63e-03
8451TNFSF14 levelsGCST902748422.63e-03
8452Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditionsUKBB000000982.62e-03
8453Free cholesterol levels in chylomicrons and extremely large VLDLGCST905009752.62e-03
8454CirrhosisGCST903198772.62e-03
8455Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T102ECGU0001022.61e-03
8456PLXNB3/SNAP23 ratioGCST903156932.61e-03
8457CholelithiasisGCST900185992.61e-03
8458Descending aorta diameterGCST902673912.60e-03
8459Triglycerides to Total Lipids in Large LDL percentageGCST904980922.60e-03
8460IL18R1 levelsGCST904695652.60e-03
8461Concentration of HDL particlesGCST904974142.60e-03
8462GLB1/IMPA1 ratioGCST903149322.59e-03
8463CD22/FCRL1 ratioGCST903137572.59e-03
8464Monounsaturated fatty acid levelsGCST905023592.59e-03
8465IL27 levelsGCST900120172.59e-03
8466IDP T1 FAST ROIs L supracalc cortexGCST900025432.59e-03
8467CA9/CBLIF ratioGCST903135952.59e-03
8468wg rh intensity-contrast frontalpoleGCST900038582.59e-03
8469TSTA3 levelsGCST904218542.58e-03
8470Second line medication for Crohn's diseaseFING000012842.58e-03
8471IDP dMRI ProbtrackX MO str rGCST900040242.58e-03
8472BA-exvivo rh volume MTGCST900028602.58e-03
8473DTI TBSS MD Sagittal stratum LGCST903846032.58e-03
8474Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T19ECGU0000192.57e-03
8475TNFRSF17 levelsGCST904709082.57e-03
8476ALCAM/IL1RL2 ratioGCST903132382.57e-03
8477LCN15 levelsGCST904697462.56e-03
8478CLIP2 levelsGCST904687822.56e-03
8479Triglycerides in very small VLDL (UKB data field 23522)GCST902696192.56e-03
8480Total lipids in medium HDLGCST904985972.56e-03
8481IDP dMRI TBSS MO Retrolenticular part of internal capsule RGCST900039722.55e-03
8482ENTPD2 levelsGCST904691202.55e-03
8483ENO2/MGLL ratioGCST903146632.55e-03
8484KRT19 levelsGCST904697172.55e-03
8485TAFA5 levelsGCST904708002.54e-03
8486FOLR2/HAVCR2 ratioGCST903148652.53e-03
8487SELE levelsGCST904705662.52e-03
8488StrokeGCST0069062.51e-03
8489SNX2 levelsGCST904707012.50e-03
8490DBNL/EDAR ratioGCST903144162.50e-03
8491Aspartate aminotransferase (AST, minimum, inv-norm transformed)GCST904751242.50e-03
8492LGMN/TIMP1 ratioGCST903153252.50e-03
8493DAPP1/PMVK ratioGCST903143962.50e-03
8494CXCL11/DKK1 ratioGCST903143342.50e-03
8495Monounsaturated fatty acids to total fatty acids percentageGCST904991112.48e-03
8496AZU1/MPO ratioGCST903134252.48e-03
8497Ganglion and cyst of synovium, tendon, and bursa (PheCode 727.4)GCST904762432.48e-03
8498KITLG levelsGCST904696912.47e-03
8499COL6A3/COLEC12 ratioGCST903141732.47e-03
8500CX3CL1 levelsGCST904689212.46e-03
8501aparc-DKTatlas rh area parstriangularisGCST900032832.46e-03
8502REG1A/TFF3 ratioGCST903157642.45e-03
8503Trigger fingerFING000013762.45e-03
8504Benign neoplasm of other and unspecified endocrine glandsFING000001592.45e-03
8505P4HB/PPP1R12A ratioGCST903155912.45e-03
8506PHLDB1 levelsGCST904702252.45e-03
8507KIR2DL2 levelsGCST904696842.44e-03
8508SCT levelsGCST904705572.44e-03
8509Monounsaturated fatty acid levelsGCST905023472.44e-03
8510Haemoglobin concentration (UKB data field 30020)GCST904680742.42e-03
8511Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T257ECGU0002572.42e-03
8512Psoriatic arthritis vs Cutaneous psoriasisGCST902439572.42e-03
8513Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T186ECGU0001862.41e-03
8514ANXA3/HCLS1 ratioGCST903132822.41e-03
8515Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T84ECGU0000842.41e-03
8516Dermatochalasis (PheCode 374.6)GCST904758942.41e-03
8517Seborrhoeic keratosisFING000012832.41e-03
8518GSTT2B levelsGCST904694152.41e-03
8519CPXM2 levelsGCST904688502.40e-03
8520CDC42BPB levelsGCST904686662.40e-03
8521ADAMTSL2 levelsGCST904682282.40e-03
8522ALPP/MSLN ratioGCST903132502.39e-03
8523Atopic dermatitisFING000001252.39e-03
8524ALB levelsGCST900259922.38e-03
8525Triglycerides in LDLGCST904984722.38e-03
8526Cholesteryl esters to total lipids in small VLDL percentage (UKB data field 23601)GCST902696982.37e-03
8527DLG4 levelsGCST904690012.37e-03
8528Neutrophil countGCST900023522.36e-03
8529TP53BP1 levelsGCST904709362.36e-03
8530FAS levelsGCST904277022.36e-03
8531FLT3LG levelsGCST904692502.35e-03
8532N2-acetyl,N6,N6-dimethyllysine levelsGCST902006972.35e-03
8533RELT levelsGCST904704532.35e-03
8534GOLGA3 levelsGCST904693752.34e-03
8535Postmenopausal breast cancerGCST904281162.33e-03
8536Biological Father: Coronary Artery / Coronary Heart DiseaseGCST904752412.33e-03
8537Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T29ECGA0000292.33e-03
8538Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T123ECGA0001232.33e-03
8539SNX15 levelsGCST904706992.32e-03
8540FCRL6 levelsGCST904692092.32e-03
8541PDGFA/PRSS27 ratioGCST903156162.31e-03
8542Volume of left basal nucleusGCST904748772.31e-03
8543CD40/TNFRSF14 ratioGCST903138302.30e-03
8544ALCAM/ICAM3 ratioGCST903132372.30e-03
8545Triglyceride levels in very large HDLGCST901326362.30e-03
8546CDH6 levelsGCST904686772.29e-03
8547Flat foot (PheCode 735.1)GCST904762482.29e-03
8548Total diffusion tensor imaging along the perivascular space indexGCST904555462.29e-03
8549Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T216ECGA0002162.29e-03
8550Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010452.29e-03
8551ING1 levelsGCST904696132.29e-03
8552X-21285 levelsGCST902005762.29e-03
8553aparc-a2009s lh volume G-cuneusGCST900029352.29e-03
8554PTRHD1 levelsGCST904703892.29e-03
8555CD300C/FOLR2 ratioGCST903137872.29e-03
8556Papulosquamous disordersFING000011442.28e-03
8557Angina pectorisFING000000862.28e-03
8558Phenylalanine levels (UKB data field 23468)GCST902695652.28e-03
8559Acute myocardial infarction | Ischaemic heart diseasesUKBB000000112.27e-03
8560Ulcerative colitisGCST904760672.27e-03
8561aparc-DKTatlas lh area pericalcarineGCST900032532.27e-03
8562Creatinine levelsGCST904972372.26e-03
8563Volume of right whole amygdalaGCST904750572.26e-03
8564Cancer of bladder (PheCode 189.2)GCST904755982.26e-03
8565ThalamNuclei lh volume L-SgGCST900027162.26e-03
8566Dermatitis and eczemaFING000004022.25e-03
8567DXO levelsGCST904690552.25e-03
8568X-11787 levelsGCST902004652.25e-03
8569Autorefraction - 3mm strong meridian angle (left) | EyesightUKBB000000672.24e-03
8570Melanomas of skin, dx or hx (PheCode 172.1)GCST904755772.23e-03
8571BCR/PLXNA4 ratioGCST903134972.23e-03
8572Primary angle-closure glaucoma (PheCode 365.2)GCST904758762.23e-03
8573Hemoglobin concentrationGCST0046152.23e-03
8574Estimated glomerular filtration rate, serum creatinine + cystain C | Other measurementUKBB000002112.23e-03
8575Mean corpuscular haemoglobin concentration | Blood countUKBB000004482.23e-03
8576CD5 levelsGCST902747732.23e-03
8577LAT2/YES1 ratioGCST903152822.23e-03
8578PPP2R5A levelsGCST904703062.22e-03
8579T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65)GCST903208842.22e-03
8580Glutamine levelsGCST900928182.22e-03
8581CD69/SNAP23 ratioGCST903138862.22e-03
8582CXCL5/SDC4 ratioGCST903143532.21e-03
8583F2R/GP6 ratioGCST903147302.20e-03
8584NFASC levelsGCST904700312.20e-03
8585Cholesteryl ester_14:0_[M+NH4]1+ levelsGCST900601972.20e-03
8586Total fatty acid levelsGCST905027112.19e-03
8587Retinal venular tortuosityGCST902703992.19e-03
8588Eosinophil countGCST900259872.19e-03
8589Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T490ECGU0004902.19e-03
8590Estimated glomerular filtration rate (cystatin c)GCST904284482.18e-03
8591Cholesterol to total lipids in very large HDL percentage (UKB data field 23630)GCST902697272.18e-03
8592Left-hemisphere dorsal attention network to left-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026902.18e-03
8593Free cholesterol levels in small HDLGCST900929482.17e-03
8594ATOX1/TMSB10 ratioGCST903133772.17e-03
8595PEAR1/SNAP23 ratioGCST903156432.17e-03
8596Blood cell traits latent factor 16 (white cell)GCST905592582.17e-03
8597Left-hemisphere visual network to accumbens white-matter structural connectivityGCST903026682.17e-03
8598PEAR1/PECAM1 ratioGCST903156412.16e-03
8599BST2 levelsGCST904684752.16e-03
8600Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T220ECGU0002202.16e-03
8601IDP dMRI ProbtrackX L1 cgh lGCST900042522.15e-03
8602DTI autoptx L1 ptr l tractGCST903851582.15e-03
8603Diacylglycerol_36:5_[M+H-H2O]1+ levelsGCST900601872.15e-03
8604PLTP levelsGCST904702622.15e-03
8605DTI TBSS MO Pontine crossing tractGCST903846212.15e-03
8606TAB2 levelsGCST904707962.14e-03
8607IFIT3 levelsGCST902415712.14e-03
8608RAB11FIP3 levelsGCST904704042.14e-03
8609CD160/KLRB1 ratioGCST903137312.13e-03
8610CD84/GP6 ratioGCST903139142.13e-03
8611CDKN2D/TACC3 ratioGCST903139922.12e-03
8612CCL11 levelsGCST902747642.12e-03
8613MB levelsGCST904698692.11e-03
8614Total lipids in medium VLDLGCST904989942.10e-03
8615Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61)GCST906685052.10e-03
8616EGLN1 levelsGCST904690872.09e-03
8617Total protein levelsGCST900187562.09e-03
8618Phosphatidate_34:2_[M-H]1- levelsGCST900602232.09e-03
8619NT5C levelsGCST904700922.09e-03
8620FSTL3 levelsGCST904692722.09e-03
8621Total lipids in HDL (UKB data field 23426)GCST902695232.08e-03
8622C1RL levelsGCST904684922.08e-03
8623Type 1 diabetesGCST900005292.08e-03
8624TIRAP levelsGCST902430322.07e-03
8625Monounsaturated fatty acid levelsGCST905023462.07e-03
8626Free cholesterol in medium HDL (UKB data field 23570)GCST902696672.07e-03
8627VPS4B levelsGCST904710472.06e-03
8628FOXO1/IRAK4 ratioGCST903148702.06e-03
8629MIF/SUSD2 ratioGCST903154522.06e-03
8630Immature reticulocyte fraction (UKB data field 30280)GCST904680792.06e-03
8631eosinophil (fraction, mean, inv-norm transformed)GCST904753002.05e-03
8632HDL x anxiety interaction (2df test)GCST905706652.05e-03
8633PDGFA/USP8 ratioGCST903156212.05e-03
8634BAG6/BMP6 ratioGCST903134502.05e-03
8635T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 103)GCST903209222.05e-03
8636Saturated fatty acids levelsGCST905021922.05e-03
8637GIPC2 levelsGCST904693472.05e-03
8638IDP dMRI TBSS ICVF Fornix cres+Stria terminalis LGCST900043662.05e-03
8639Mean corpuscular volume (UKB data field 30040)GCST904680862.05e-03
8640T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81)GCST903206442.05e-03
8641CNP levelsGCST904687982.04e-03
8642Total concentration of lipoprotein particlesGCST905001012.04e-03
8643ROBO1/SPON1 ratioGCST903157832.04e-03
8644Stable angina pectorisGCST900186952.03e-03
8645Triacylglycerol (50:0) [NL-18:0] levelsGCST900251512.03e-03
8646Plasma homoarginine levels in chronic kidney diseaseGCST902653452.02e-03
8647BAMBI levelsGCST904684202.02e-03
8648EFEMP1/FSTL3 ratioGCST903145952.02e-03
8649B4GALT1/IFNGR1 ratioGCST903134302.02e-03
8650Acquired toe deformities (PheCode 735.2)GCST904762492.02e-03
8651EIF4G1/TBC1D23 ratioGCST903146392.01e-03
8652GZMA levelsGCST902413232.01e-03
8653GTPBP2 levelsGCST904694172.01e-03
8654Triglycerides to Total Lipids in Large LDL percentageGCST904981012.01e-03
8655CD200/CLEC4G ratioGCST903137462.01e-03
8656Triglyceride to phosphoglyceride ratioGCST904544832.01e-03
8657CA9 levelsGCST904685182.01e-03
8658DTI TBSS L3 Superior cerebellar peduncle RGCST903845362.01e-03
8659Triacylglycerol_50:4_[M+NH4]1+ levelsGCST900604662.00e-03
8660PRTN3/RETN ratioGCST903157342.00e-03
8661mean corpuscular volume (MCV, mean, inv-norm transformed)GCST904754702.00e-03
8662EIF4E levelsGCST904690962.00e-03
8663T1 FreeSurfer DKT lh precentral thicknessGCST903842462.00e-03
8664Ascending aorta distensibilityGCST902673851.99e-03
8665Clonal haematopoiesis of indeterminate potential (TET2 mutation)GCST901652811.99e-03
8666Eosinophil percentage of white cellsGCST900023821.99e-03
8667Triglycerides to Total Lipids in IDL percentageGCST904976821.98e-03
8668Polyunsaturated fatty acids to total fatty acids percentageGCST905026481.98e-03
8669CELA3A/CTRC ratioGCST903140121.98e-03
8670OPHN1 levelsGCST904701261.98e-03
8671T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119)GCST903206821.98e-03
8672FOXO1/MAP4K5 ratioGCST903148721.98e-03
8673Fractured bone site(s) - Other bones | Medical conditionsUKBB000002561.98e-03
8674T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 24)GCST903205871.98e-03
8675Eosinophill percentage | Blood countUKBB000002071.97e-03
8676WFDC5 levelsGCST900895981.97e-03
8677Triacylglycerol_52:4_[M+NH4]1+ levelsGCST900605081.97e-03
8678aparc-DKTatlas lh area precentralGCST900032561.97e-03
8679Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000007171.97e-03
8680aseg lh volume Cerebellum-CortexGCST900026191.96e-03
8681Atopic/contact dermatitis due to other or unspecified (PheCode 939)GCST904762891.96e-03
8682Thyroid peroxidase antibody levels in pregnancyGCST904352011.96e-03
8683Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T134ECGU0001341.96e-03
8684KDR/VWF ratioGCST903152451.96e-03
8685Eustachian tube disorders (PheCode 381.2)GCST904759041.96e-03
8686Carotid plaqueGCST0074351.96e-03
8687REG3A levelsGCST904704491.96e-03
8688TFF3 levelsGCST904708371.95e-03
8689Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T482ECGU0004821.95e-03
8690CPA1/CPB1 ratioGCST903142021.95e-03
8691CLIP2/LAT2 ratioGCST903141281.95e-03
8692aparc-a2009s lh area G-cingul-Post-ventralGCST900033061.95e-03
8693CXCL11/VTA1 ratioGCST903143371.95e-03
8694Citrulline levelsGCST902004031.94e-03
8695LONP1 levelsGCST904697851.94e-03
8696Vanillylmandelate (VMA) levelsGCST902003091.94e-03
8697METAP2/RILP ratioGCST903154331.94e-03
8698IDS levelsGCST904695071.94e-03
8699ERBB4 levelsGCST904691411.94e-03
8700DMP1 levelsGCST904690071.94e-03
8701IDP T1 FAST ROIs brain stemGCST900025611.94e-03
8702SAMD9L levelsGCST904705241.93e-03
8703Total cholines levelsGCST904971831.93e-03
8704CAG-269 sp001915995 abundance in stoolGCST900322661.92e-03
8705CCL17/F2R ratioGCST903136861.92e-03
8706Non-cancer illness code, self-reported - asthma | Medical conditionsUKBB000005061.92e-03
8707PRR15 levelsGCST904247901.92e-03
8708ERBIN/TBC1D23 ratioGCST903146981.92e-03
8709Phospholipids to total lipids ratio in chylomicrons and extremely large VLDLGCST900930491.92e-03
8710Actinic keratosisFING000000131.91e-03
8711Comorbidity of gastric and duodenal ulcersGCST902709291.91e-03
8712Other non-epithelial cancer of skin | neoplasmsUKBB000006151.91e-03
8713Chronic obstructive pulmonary disease in current smokersGCST900165931.91e-03
8714DUSP3 levelsGCST904690531.90e-03
8715CD27/TNFRSF13B ratioGCST903137771.90e-03
8716DSG3/DSG4 ratioGCST903145581.90e-03
8717Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T188ECGA0001881.90e-03
8718aparc-DKTatlas rh area cuneusGCST900032681.90e-03
8719EDAR/TNFSF12 ratioGCST903145911.89e-03
8720AGRP levelsGCST900120631.89e-03
8721CD160/NCR1 ratioGCST903137321.88e-03
8722Right-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027771.88e-03
87231-margaroyl-2-linoleoyl-GPC (17:0/18:2) metabolite levelGCST906160131.88e-03
8724Lysophosphatidylcholine (26:0) [sn1] levelsGCST900241881.87e-03
8725PPP1R12A/SKAP2 ratioGCST903157101.87e-03
8726ADAM22 levelsGCST904682181.87e-03
8727Atrial fibrillation/atrial flutterGCST900185761.87e-03
8728DTI TBSS MD Sagittal stratum RGCST903846021.87e-03
8729IL5RA/TNFRSF13B ratioGCST903151641.87e-03
8730BTD levelsGCST904684771.87e-03
8731T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82)GCST903206451.86e-03
8732DNAJB6 levelsGCST904690141.86e-03
8733FAM3B/GPA33 ratioGCST903147781.86e-03
8734HTRA2/SNAP29 ratioGCST903150981.86e-03
8735Arm predicted mass (right) | Impedance measuresUKBB000000501.85e-03
8736OBP2B levelsGCST904701131.85e-03
8737HAMP levelsGCST904516831.85e-03
8738AsthmaGCST900143251.85e-03
8739Other malignant neoplasms of skin | Melanoma and other malignant neoplasms of skinUKBB000006131.85e-03
8740JAM2/TNFRSF19 ratioGCST903152411.85e-03
8741F7 levelsGCST904691711.84e-03
8742Free cholesterol to total lipids in large VLDL percentage (UKB data field 23592)GCST902696891.84e-03
8743TMSB10/TREML2 ratioGCST903159231.84e-03
8744Hippocampal subfield left CA3 volume (head)GCST902679411.84e-03
8745NOTCH1/TIE1 ratioGCST903155461.84e-03
87464-hydroxyglutamate levelsGCST901998901.84e-03
8747Lymphoid neoplasms (P-cell phenocluster)GCST906247371.84e-03
8748HematocritGCST900023041.83e-03
8749GPNMB levelsGCST904693931.83e-03
8750EPHB4/ESAM ratioGCST903146791.83e-03
8751RGMB/SMOC2 ratioGCST903157701.83e-03
8752RETN levelsGCST904704571.82e-03
8753CDC37/SNX9 ratioGCST903139361.82e-03
8754TNR levelsGCST904709291.82e-03
8755Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T108ECGU0001081.81e-03
8756PMVK levelsGCST904702721.81e-03
8757Retinal thickness (functional principal component 1)GCST904557211.81e-03
8758Pelvic organ prolapseGCST901024701.81e-03
8759DTI autoptx MD unc r tractGCST903852461.81e-03
8760Inguinal hernia (PheCode 550.1)GCST904760601.81e-03
8761Docosahexaenoic acid levelsGCST905019861.81e-03
8762Calcium | Blood biochemistryUKBB000001141.81e-03
8763Ovarian cancer-related tumor marker CA 125 levelsGCST900120781.80e-03
8764HDL cholesterolGCST900187361.80e-03
8765REG1A/REG3A ratioGCST903157611.79e-03
8766CXCL5/SPARC ratioGCST903143551.79e-03
8767MYOC/RGMB ratioGCST903155081.79e-03
8768VSIG2 levelsGCST904710511.78e-03
8769CCL11/CCL2 ratioGCST903136721.78e-03
8770GZMH levelsGCST904694251.78e-03
8771ERP44/SUMF2 ratioGCST903147101.78e-03
8772Bone marrow fat fraction of lumbar vertebra 1GCST906523861.78e-03
8773FABP6 levelsGCST904691781.77e-03
8774KLK11/KLK8 ratioGCST903152541.76e-03
8775Right hippocampal volumeGCST902679741.76e-03
8776Mean corpuscular hemoglobin concentrationGCST900023291.76e-03
8777MED18/SH2B3 ratioGCST903154121.75e-03
8778Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T259ECGU0002591.75e-03
8779T1 FreeSurfer pial rh lateraloccipital areaGCST903858321.75e-03
8780DTI TBSS L3 Sagittal stratum LGCST903845551.74e-03
8781Total fatty acid levelsGCST905022181.74e-03
8782GSTA1 levelsGCST904694111.74e-03
8783HCLS1/LAT ratioGCST903150411.74e-03
8784CXCL3/CXCL5 ratioGCST903143441.74e-03
8785CTSZ levelsGCST904689181.74e-03
8786hematocrit (mean, inv-norm transformed)GCST904753411.73e-03
8787Left-hemisphere control network to accumbens white-matter structural connectivityGCST903027581.73e-03
8788Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T149ECGU0001491.73e-03
8789Hemoglobin concentrationGCST900023111.72e-03
8790SFTPA2/SFTPD ratioGCST903158391.72e-03
8791aparc-a2009s rh area S-collat-transv-antGCST900034201.72e-03
8792Acute sinusitisFING000000311.72e-03
8793T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122)GCST903209411.71e-03
8794BPIFB1 levelsGCST904684621.71e-03
8795GDNF levelsGCST904693231.71e-03
8796Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T258ECGU0002581.71e-03
8797Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T83ECGU0000831.71e-03
8798Saturated fatty acid levelsGCST900929801.70e-03
8799CTSF/SMPDL3A ratioGCST903143161.70e-03
8800Plasma glycocholenate sulfate* levels in chronic kidney diseaseGCST902652911.70e-03
8801IDP T1 FAST ROIs L cerebellum crus IGCST900025691.70e-03
8802AsthmaGCST904681121.69e-03
8803CCN2/EDAR ratioGCST903137111.69e-03
8804Monounsaturated fatty acid levelsGCST905020361.69e-03
8805LYN/TACC3 ratioGCST903153501.69e-03
8806BIN2/EREG ratioGCST903135031.69e-03
8807IDP T1 FAST ROIs V cerebellum XGCST900025881.69e-03
8808DNAJC6 levelsGCST904690171.68e-03
8809RGMB/TNFRSF21 ratioGCST903157721.68e-03
8810CREG1/SMPDL3A ratioGCST903142521.68e-03
8811NFKBIE levelsGCST904700391.68e-03
8812Lymphangioleiomyomatosis (sporadic)GCST0083111.68e-03
8813CCL17/CCL22 ratioGCST903136821.68e-03
8814Seborrhoeic dermatitisFING000012821.68e-03
8815REG1B levelsGCST904704481.68e-03
8816PON3 levelsGCST904702871.67e-03
8817CCL13/CCL2 ratioGCST903136751.67e-03
8818Omega-6 fatty acid levelsGCST905020951.67e-03
8819Waist circumference adjusted for body mass indexGCST900200291.67e-03
8820Other disorders of fluid, electrolyte and acid-base balanceFING000010271.67e-03
8821DPEP2 levelsGCST904690311.67e-03
8822Omega-3 fatty acid levelsGCST905020551.67e-03
8823aparc-a2009s lh volume G-oc-temp-med-LingualGCST900029461.66e-03
8824RGMB/THY1 ratioGCST903157711.66e-03
8825aparc-a2009s lh area S-collat-transv-antGCST900033461.66e-03
8826Left-hemisphere limbic network to thalamus white-matter structural connectivityGCST903027361.65e-03
8827BCL2L11/RAB6A ratioGCST903134841.65e-03
8828FAM174A levelsGCST902419141.65e-03
8829DLL1/NECTIN4 ratioGCST903144971.65e-03
8830Cholesterol, totalGCST0007601.65e-03
8831SMPD1 levelsGCST904706841.65e-03
8832CD274/EFNA4 ratioGCST903137681.65e-03
8833Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T115ECGA0001151.64e-03
8834Liver enzyme levels (alanine transaminase)GCST900134051.64e-03
8835CD164/SIAE ratioGCST903137441.64e-03
8836Mean arterial pressure (BMI adjusted)GCST903351691.64e-03
8837CANT1/ROR1 ratioGCST903136201.64e-03
8838SEZ6L levelsGCST904706071.64e-03
8839CD83/LAMP3 ratioGCST903139061.64e-03
8840Colorectal cancer (PheCode 153)GCST0083721.64e-03
8841NTN4 levelsGCST902420491.64e-03
8842SIGLEC10 levelsGCST904706301.64e-03
8843Sphingomyelin_40:2_[M+H]1+ levelsGCST900603521.63e-03
8844IDP T1 FAST ROIs R cerebellum XGCST900025891.63e-03
8845T1 FreeSurfer DKT rh lateraloccipital volumeGCST903843571.63e-03
8846CTF1/ITGB1BP2 ratioGCST903143051.63e-03
8847CD22 levelsGCST904686101.63e-03
8848GP1BA/SELP ratioGCST903149581.63e-03
8849Thoracic aortic aneurysmFING000013571.62e-03
8850Hearing difficulty and hearing difficulty with background noiseGCST902457761.62e-03
8851Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T121ECGU0001211.62e-03
8852HippSubfield rh volume GC-ML-DG-headGCST900027011.62e-03
8853PPP1R2/TMSB10 ratioGCST903157211.62e-03
8854Androstenediol (3alpha, 17alpha) monosulfate (3) levelsGCST901998561.62e-03
8855IPCEF1/TBCB ratioGCST903151871.62e-03
8856Thyroid peroxidase antibody positivity in pregnancyGCST904352021.61e-03
8857TCL1A/TNFRSF13C ratioGCST903159121.61e-03
8858EDN1 levelsGCST904690731.61e-03
8859Alkylphosphatidylcholine (O-16:0/16:0) levelsGCST900249131.61e-03
8860GSTT2 levelsGCST900866521.61e-03
8861PCDH17/THBD ratioGCST903156071.60e-03
8862Asthma and allergyFING000001151.60e-03
8863IDP T1 FAST ROIs L cerebellum VGCST900025641.60e-03
8864Free Cholesterol to Total Lipids in Large HDL percentageGCST904977901.60e-03
8865Thyroid peroxidase antibody positivity with euthyroid in pregnancyGCST904352031.60e-03
8866ANXA1 levelsGCST904683161.60e-03
8867ICAM2/SELE ratioGCST903151201.60e-03
8868CD74/TNFRSF21 ratioGCST903138971.60e-03
8869ERBB3/IL1R2 ratioGCST903146891.60e-03
8870aseg lh intensity Accumbens-areaGCST900037741.60e-03
8871FCER2 levelsGCST904691991.59e-03
8872Prurigo nodularisFING000012201.59e-03
8873rfMRI connectivity (ICA100 edge 931)GCST900057841.59e-03
8874Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T119ECGA0001191.59e-03
8875ENTPD6 levelsGCST904691221.59e-03
8876Triglycerides to Total Lipids in Medium LDL percentageGCST904988811.58e-03
8877Linoleic acid to total fatty acids percentageGCST905023371.58e-03
8878CA4/SELE ratioGCST903135871.58e-03
8879DTYMK levelsGCST904690491.58e-03
8880Sphingomyelin_36:2_[M+H]1+ levelsGCST900602631.58e-03
8881DCTPP1 levelsGCST904689611.58e-03
8882PTPN1 levelsGCST904703761.57e-03
8883CASP3/MESD ratioGCST903136361.57e-03
8884ATP5IF1/DECR1 ratioGCST903133821.57e-03
8885Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T65ECGA0000651.57e-03
8886CD22/TCL1A ratioGCST903137601.57e-03
8887SHMT1 levelsGCST904706271.57e-03
8888MMP8/OLR1 ratioGCST903154641.56e-03
8889DHEAS levelsGCST901996731.56e-03
8890ANGPT1/CPXM1 ratioGCST903132621.56e-03
8891SERPINF2 levelsGCST904705991.56e-03
8892BCAM levelsGCST904684251.56e-03
8893Calcium levelsGCST900187311.56e-03
8894IDP dMRI TBSS ISOVF Posterior thalamic radiation LGCST900045061.56e-03
8895NPL levelsGCST904700721.56e-03
8896Free cholesterol in HDL (UKB data field 23422)GCST902695191.56e-03
8897OLR1/PLAUR ratioGCST903155841.56e-03
8898Concentration of medium HDL particles (UKB data field 23565)GCST902696621.56e-03
8899CALCOCO1/PDLIM7 ratioGCST903136071.55e-03
8900Triglyceride levels in very large HDLGCST900930141.55e-03
8901Volume of left accessory basal nucleusGCST904748741.54e-03
8902PNMA1 levelsGCST904702761.54e-03
8903Phosphatidylcholine levelsGCST904992401.54e-03
8904ACVRL1/TNFRSF9 ratioGCST903131601.54e-03
8905MAVS/ZBTB16 ratioGCST903154011.54e-03
8906FABP1/RBP2 ratioGCST903147531.53e-03
8907IST1 levelsGCST904696321.53e-03
8908Free testosterone levelsGCST902398261.53e-03
8909Skin color (cheek, ITA value)GCST905027801.53e-03
8910T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 114)GCST903206771.53e-03
8911DTNB levelsGCST904690461.53e-03
8912RBPMS2 levelsGCST904704411.52e-03
8913Cholesteryl Esters to Total Lipids in Medium HDL percentageGCST904985501.52e-03
8914PPP1R12A/TXNDC5 ratioGCST903157141.52e-03
8915FABP2/LGALS4 ratioGCST903147561.52e-03
8916ARSA/CD164 ratioGCST903133511.52e-03
8917DLL1/NOTCH1 ratioGCST903144981.52e-03
8918Fat-free massGCST0070631.51e-03
8919Varicose veins of lower extremity, symptomtic (PheCode 454.11)GCST904760141.51e-03
8920Primary angle-closure glaucomaFING000012101.51e-03
8921Omega-6 fatty acid levelsGCST905025141.50e-03
8922LRIG3 levelsGCST904697951.50e-03
8923CALCOCO2 levelsGCST904685311.50e-03
8924IPCEF1 levelsGCST904696241.50e-03
8925IDP dMRI TBSS FA External capsule LGCST900039101.49e-03
8926FGFBP3 levelsGCST904692321.49e-03
8927Hyperparathyroidism (PheCode 252.1)GCST904756931.49e-03
8928Rheumatoid arthritisGCST901322231.49e-03
8929CMIP levelsGCST904687951.49e-03
8930ADH4 levelsGCST904682441.49e-03
8931eGFR in diabetes mellitus (strict) case-control group (minimal adjustment)GCST906247811.49e-03
8932MAVS levelsGCST904698661.49e-03
8933aparc-a2009s lh area S-calcarineGCST900033401.48e-03
8934Sphingomyelin_40:0_[M+H]1+ levelsGCST900603641.48e-03
8935Volume of right anterior amygdaloid areaGCST904749041.48e-03
8936COL18A1 levelsGCST904688121.48e-03
8937LAYN levelsGCST904697421.48e-03
8938Eosinophil countGCST900022981.48e-03
8939BA-exvivo lh volume entorhinalGCST900028481.48e-03
8940Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T483ECGU0004831.48e-03
8941Cholesteryl Esters in IDLGCST904975251.47e-03
8942CPXM1/DKK1 ratioGCST903142181.47e-03
8943SCARF2 levelsGCST904705371.47e-03
8944Corneal hysteresis (left) | Intraocular pressureUKBB000001481.46e-03
8945Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T104ECGU0001041.46e-03
8946MAVS/MED18 ratioGCST903153891.46e-03
8947LDLR/PCSK9 ratioGCST903153111.46e-03
8948Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T189ECGA0001891.45e-03
8949T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 93)GCST903209121.45e-03
8950Eosinophil countGCST900023811.45e-03
8951METAP2/PLPBP ratioGCST903154321.45e-03
8952red cell diameter width (RDW, maximum, inv-norm transformed)GCST904763571.45e-03
8953AIDA levelsGCST904682651.45e-03
8954CD164/LGMN ratioGCST903137411.45e-03
8955LAIR2 levelsGCST904697291.45e-03
8956CSRP3 levelsGCST904688921.44e-03
8957IDP dMRI ProbtrackX MO str lGCST900040231.44e-03
8958Oral glucose tolerance test-2hGCST905664231.44e-03
8959Rheumatoid arthritis and other inflammatory (PheCode 714)GCST904762281.44e-03
8960FCRL1 levelsGCST904692051.44e-03
8961hematocrit (maximum, inv-norm transformed)GCST904753381.44e-03
8962LDLRAP1 levelsGCST904697491.44e-03
8963Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T225ECGU0002251.43e-03
8964CD59/PI3 ratioGCST903138581.43e-03
8965Ribothymidine levels in chronic kidney diseaseGCST902575541.42e-03
8966Right-hemisphere default mode network to hippocampus white-matter structural connectivityGCST903028481.42e-03
8967DCTD levelsGCST904689571.42e-03
8968CLEC1B/HBEGF ratioGCST903140921.42e-03
8969Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T90ECGA0000901.42e-03
8970Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T486ECGU0004861.42e-03
8971Monounsaturated fatty acids levels (UKB data field 23447)GCST902695441.42e-03
8972Total lipids in very small VLDL (UKB data field 23517)GCST902696141.42e-03
8973IDP dMRI ProbtrackX MO atr rGCST900040031.42e-03
8974ALDH1A1/PKLR ratioGCST903132451.41e-03
8975HDL cholesterol levelsGCST904973401.41e-03
8976Right hippocampal volume (tail)GCST902679731.41e-03
8977KAZALD1 levelsGCST904696651.41e-03
8978Bell's palsyFING000001441.41e-03
8979Aortic aneurysmFING000001021.41e-03
8980CKAP4/TNFRSF4 ratioGCST903140761.41e-03
8981AARSD1/UBAC1 ratioGCST903131351.41e-03
8982SCARF1 levelsGCST904705361.41e-03
8983Immature fraction of reticulocytesGCST900259711.40e-03
8984Mean spheric corpuscular volumeGCST900023971.40e-03
8985DOK1 levelsGCST904690281.40e-03
8986DTI TBSS L3 Posterior thalamic radiation RGCST903845521.40e-03
8987FIS1/HSPA1A ratioGCST903148251.39e-03
8988ROR1 levelsGCST904704921.39e-03
8989Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T96ECGU0000961.39e-03
8990Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T112ECGA0001121.39e-03
8991CD300A levelsGCST904686191.39e-03
8992Eosinophil countGCST900022991.39e-03
8993PDAP1 levelsGCST904701791.38e-03
8994CLEC11A levelsGCST904687641.38e-03
8995Triacylglycerol_52:5_[M+NH4]1+ levelsGCST900605061.38e-03
8996CD79B/TNFRSF4 ratioGCST903139031.38e-03
8997FOXO1/SNAP23 ratioGCST903148751.38e-03
8998T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 102)GCST903209211.38e-03
8999ADGRE2/IFNGR1 ratioGCST903131771.38e-03
9000Urine adenosine levels in chronic kidney diseaseGCST902647571.38e-03